How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods.
Jun TeruyaKaren BruzdoskiLisa HenschShiu-Ki Rocky HuiVadim KostousovPublished in: International journal of laboratory hematology (2021)
dTT1:10 appears to be more suitable for routine practice due to fewer variations and lower cost for monitoring bivalirudin in pediatric ECLS.